NCT01480869 2026-03-12
VITACAL
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 3 Completed
Clinical Trials
16 trialsNCT04094688 2026-03-03
SOLARIS
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT05838716 2026-01-15
ViPER
University of Rochester
Phase 3 Recruiting
NCT01169259 2025-11-06
VITAL
Brigham and Women's Hospital
Phase 3 Active not recruiting
NCT01748448 2025-02-17
ViDMe
Universitaire Ziekenhuizen KU Leuven
Phase 3 Completed
NCT03078855 2024-09-04
ILyAD
University of Rochester
Phase 3 Completed
NCT04442412 2022-08-26
FIL_PREVID
Fondazione Italiana Linfomi - ETS
Phase 3 Recruiting
NCT01646437 2021-09-16
TIPS-3
Population Health Research Institute
Phase 3 Completed
NCT04115982 2021-08-31
D3NERV
University Hospital, Caen
Phase 3 Unknown
NCT00058188 2020-12-08
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
Northwestern University
Phase 3 Terminated
NCT01518959 2020-07-16
D-HEM
Semmelweis University
Phase 3 Terminated
NCT03792984 2019-06-06
The Effect of Calcium and Vitamin D Supplements on Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Patients
Damascus University
Phase 3 Completed
NCT01264874 2018-01-31
MelaViD
European Institute of Oncology
Phase 3 Terminated
NCT03389659 2018-01-03
XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT00043069 2016-12-07
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00022087 2016-07-19
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed